The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer.This test could assist with prompt detection and intervention for this prevalent cancer type. Doctors and specialists can offer appropriate guidance for people who would most benefit from it.Currently, the test is not covered by Medicare, but this could change in the future, as well as potential coverage from private health insurance groups.